E-DRUG: Minilab project now by the Global Pharma Health Fund
[Response to message posted June 5 on oseltamivir]
Dear Mr. Kitutu,
I must say you have been wrongly informed about the future of the Minilab
project: it is by far not dead. In fact, it is more lively than ever before. I
am wondering who is disseminating such a nonsense.
>From next month onward, the Minilab project will be operated by the Global
Pharma Health Fund (new GPHF), a charitable organisation initiated and
maintained by Merck KGaA*.
Apart from a new name and sponsorship, there will be no changes whatsoever.
All contact details including email and homepage address will stay the same and
I will continue to manage the project as succesfully as in the past.
More information about the new GPHF set up will be formally issued to all our
project partners onset next month.
I look forward to receiving continuous support from existing and new project
German/Global Pharma Health Fund e.V.
Walther-von-Cronberg Platz 6,
60594 Frankfurt, Germany,
Head Office: T: +49-69-96238760-0, F: +49-69-96238760-9, firstname.lastname@example.org
Project Office: T: +49-69-46939-662, F: +49-69-46939-852,
The new GPHF is a charitable organisation initiated by Merck KGaA*
* Merck is a global pharmaceutical and chemical company with sales of EUR 6.3
billion in 2006, a history that began in 1668, and a future shaped about 35,000
employees (including Merck Serono) in 56 countries. Its success is
characterized by innovations from entrepreneurial employees. Merck's operating
activities come under the umbrella of Merck KGaA, in which the Merck family
holds an approximately 70% interest and free shareholders own the remaining
approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and
has been an independent company ever since.